CASTRATION-RESISTANT PROSTATE CANCER
Clinical trials for CASTRATION-RESISTANT PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new CASTRATION-RESISTANT PROSTATE CANCER trials appear
Sign up with your email to follow new studies for CASTRATION-RESISTANT PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough prostate cancer: trial tests Two-Pronged attack
Disease control Not yet recruitingThis study is testing whether adding a new drug called evofosfamide to standard hormone therapy can help control advanced prostate cancer that has stopped responding to initial treatments. It will involve about 35 men whose cancer has spread and progressed despite prior therapy. …
Matched conditions: CASTRATION-RESISTANT PROSTATE CANCER
Phase: PHASE2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New imaging agent seeks to light up hidden cancer
Diagnosis Not yet recruitingThis early-stage study is testing a new imaging agent called 111In-ABD147 to see if it can detect metastatic cancer in patients with solid tumors. The agent is designed to attach to a protein called DLL3, which is often found on certain cancer cells. The main goals are to see if …
Matched conditions: CASTRATION-RESISTANT PROSTATE CANCER
Phase: EARLY_PHASE1 • Sponsor: Thomas Hope • Aim: Diagnosis
Last updated Mar 30, 2026 14:33 UTC